Shandong Jingwei Pharmaceutical

Shandong Jingwei Pharmaceutical is a China-based pharmaceutical company headquartered in Zibo, Shandong, specializing in the research, development, and production of chemical drugs and active pharmaceutical ingredients (APIs). The company focuses primarily on chronic metabolic diseases, with a strong emphasis on diabetes treatments such as Metformin and Gliclazide. Operating with GMP-certified facilities, it provides both finished dosage forms and high-quality APIs to domestic and international markets. Shandong Jingwei is a publicly traded entity on the National Equities Exchange and Quotations (NEEQ) in China. In addition to its own product line, the company offers contract manufacturing (CMO) services for small molecule therapeutics.